Equillium Inc (EQ)

$1.56 0.02 (1.30%)

16:00 EDT EQ Stock Quote Delayed 30 Minutes

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Why Is Equillium (EQ) Stock Soaring 20% Today?

More Articles

Volume:

Previous Close -

Market Cap 53.69M

PE Ratio -14.18

EPS -0.11

Volume (Avg. Vol.) 31,380

Day's Range $1.53 - $1.60

52-Week Range $0.45 - $3.25

Dividend & Yield N/A (N/A)

EQ Stock Predictions, Articles, and Equillium Inc News

From InvestorPlace
From the Web

EQ Stock: 6 Things to Know about Biotech Company Equillium

By William White, InvestorPlace Writer Oct 30, 2020

Equillium (EQ) stock is seeing gains on Friday after getting the go-ahead from the FDA for a drug trial treating the coronavirus.

Equillium News: Why EQ Stock Is Plummeting 46% Today

By William White, InvestorPlace Writer Jul 14, 2020

Equillium (EQ) news for Tuesday concerning a deal with Jefferies (JEF) to sell shares of EQ stock has it falling on Tuesday.

Stock Market Today: Is the Rally Ruined?; Tesla’s New Record

By Bret Kenwell, InvestorPlace Contributor Jan 3, 2020

Stocks were hit for what feels like the first time in a long time. Here's what happened in the stock market today.

Equillium approves $7.5M share buyback, stock jumps more than 30% after hours (NASDAQ:EQ)

From Seeking Alpha Aug 2, 2023

Clinical-stage biotech Equillium (EQ) on Thursday said its board had approved a share buyback of up to $7.5M. Read more here.

Metacrine, Equillium call off merger (NASDAQ:EQ)

From Seeking Alpha Dec 23, 2022

Metacrine (MTCR) and Equillium (EQ) have jointly agreed to terminate their merger agreement.

SVB Securities Keeps Their Buy Rating on Equillium (EQ)

From TipRanks Nov 16, 2022

In a report released on November 14, Thomas Smith from SVB Securities reiterated a Buy rating on Equillium (EQ – Research Report), with a price target of $12....

Equillium (EQ) Gets a Buy from H.C. Wainwright

From TipRanks Nov 4, 2022

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Equillium (EQ – Research Report), with a price target of $20.00. The...

H.C. Wainwright Reaffirms Their Buy Rating on Equillium (EQ)

From TipRanks Oct 31, 2022

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Equillium (EQ – Research Report) today and set a price target of $20.00. The company’s ...

Equillium (NASDAQ: EQ) Soars After Positive Results From Clinical Study

From TipRanks Sep 27, 2022

Shares of Equillium (NASDAQ: EQ) soared in morning trading on Tuesday after the clinical-stage biotechnology company announced positive interim clinical results fro...

ADVERTISEMENT